Wei, Le; Ahmadi, Matthew N; Blodgett, Joanna M; Aguiar, Elroy J; Biswas, Raaj Kishore; Koemel, Nicholas A; Del Pozo Cruz, Borja; Wei, Le; Ahmadi, Matthew N; Blodgett, Joanna M; Aguiar, Elroy J; Biswas, Raaj Kishore; Koemel, Nicholas A; Del Pozo Cruz, Borja; Stamatakis, Emmanuel; - view fewer (2025) Does the Choice of Stepping Intensity Metric Influence Dose-Response Associations with Mortality? Analysis on UK Population Cohort Study of 65,253 Adults. Medicine & Science in Sports & Exercise 10.1249/MSS.0000000000003887. (In press).

Preview

Text does_the_choice_of_stepping_intensity_metric.937.pdf - Accepted Version Download (1MB) | Preview

Abstract

Background: Evidence on the potential mortality gain of higher free-living stepping intensity is limited and equivocal, potentially due to the inconsistent usage among various estimation metrics. To estimate the difference in the association with mortality risk across different stepping intensity metrics, we aimed to compare different metrics in terms of their multivariable-adjusted associations with all-cause (ACM), cardiovascular disease (CVD), and cancer mortality. // Methods: This cohort study included UK biobank participants wearing wrist-worn accelerometers. We included eight peak cadence metrics, defined as the highest averaged steps/min across eight different time windows (1-, 5-, 10-, 15-, 20-, 25-, 30-, 60-min), and two non-peak-cadence metrics including average daily cadence (steps/accelerometer wearing minutes) and purposeful cadence (averaged steps/min for minutes ≥40 steps). For each metric, we first standardized each individual’s absolute cadence using (individual’s absolute cadence–mean cadence)/standard deviation. We then estimated their dose-response associations using Cox-restricted-cubic-spline models and compared them on overlay plots. // Results: Among 65,253 participants (mean age: 61.5 years [SD: 7.8]; 57% female) followed for 8.0 (median) years, all peak-cadence metrics and the average daily cadence exhibited similar positive dose-response associations with mortality. For example, the medians of the individual-level standardized cadence and hazard ratios (HR) across peak 1-, 30-, and 60-min cadence were: ACM, -0.17 steps/min (HR: 0.71 [95%CI: 0.64, 0.80], -0.15 (0.66 [0.59, 0.74]) and -0.15 (0.66 [0.59, 0.75]), respectively; CVD mortality, -0.17 steps/min (HR: 0.63 [95%CI: 0.51, 0.78]), -0.15 (0.57 [0.46, 0.71]), and -0.15 (0.57 [0.46, 0.71]); cancer mortality, -0.17 steps/min (HR: 0.88 [95%CI: 0.75, 1.03]), -0.15 (0.89 [0.75, 1.04]), -0.16 (0.93 [0.78, 1.09]). Purposeful cadence was not associated with mortality (e.g., median of the individual-level standardized cadence: 0.59 steps/min; HR: 0.99 (95% CI: 0.86, 1.15)]). // Conclusions: This study suggested that peak cadence and average cadence metrics can be used interchangeably to quantify the associations of stepping intensity with long-term health outcomes.

Download activity - last month

Export as JSONCSVXML

Download activity - last 12 months

Export as CSVXMLJSON

Downloads by country - last 12 months

Export as XMLCSVJSON

Archive Staff Only

View Item